Your browser doesn't support javascript.
loading
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Kotmayer, Lili; László, Tamás; Mikala, Gábor; Kiss, Richárd; Lévay, Luca; Hegyi, Lajos László; Gróf, Stefánia; Nagy, Tibor; Barna, Gábor; Farkas, Péter; Weisinger, Júlia; Nagy, Zsolt; Balogh, Alexandra; Masszi, Tamás; Demeter, Judit; Sulák, Adrienn; Kohl, Zoltán; Alizadeh, Hussain; Egyed, Miklós; Pettendi, Piroska; Gergely, Lajos; Plander, Márk; Pauker, Zsolt; Masszi, András; Matolcsy, András; Szász, Róbert; Bödör, Csaba; Alpár, Donát.
Affiliation
  • Kotmayer L; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • László T; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Mikala G; South-Pest Central Hospital, National Institute of Hematology and Infectology, 1097 Budapest, Hungary.
  • Kiss R; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Lévay L; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Hegyi LL; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Gróf S; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Nagy T; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Barna G; Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Farkas P; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Weisinger J; Department of Internal Medicine and Hematology, Semmelweis University, 1085 Budapest, Hungary.
  • Nagy Z; Department of Internal Medicine and Hematology, Semmelweis University, 1085 Budapest, Hungary.
  • Balogh A; Department of Internal Medicine and Hematology, Semmelweis University, 1085 Budapest, Hungary.
  • Masszi T; Department of Internal Medicine and Hematology, Semmelweis University, 1085 Budapest, Hungary.
  • Demeter J; Department of Internal Medicine and Hematology, Semmelweis University, 1085 Budapest, Hungary.
  • Sulák A; Department of Internal Medicine and Oncology, Semmelweis University, 1085 Budapest, Hungary.
  • Kohl Z; 2nd Department of Internal Medicine and Cardiology Center, University of Szeged, 6725 Szeged, Hungary.
  • Alizadeh H; 1st Department of Internal Medicine, Clinical Centre, University of Pécs, 7622 Pécs, Hungary.
  • Egyed M; 1st Department of Internal Medicine, Clinical Centre, University of Pécs, 7622 Pécs, Hungary.
  • Pettendi P; Kaposi Mór University Teaching Hospital of County Somogy, 7400 Kaposvár, Hungary.
  • Gergely L; Hetényi Géza Hospital, Clinic of County Jász-Nagykun-Szolnok, 5000 Szolnok, Hungary.
  • Plander M; Division of Hematology, Department of Internal Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Pauker Z; Markusovszky University Teaching Hospital, 9700 Szombathely, Hungary.
  • Masszi A; Borsod-Abaúj-Zemplén County Hospital and University Teaching Hospital, 3515 Miskolc, Hungary.
  • Matolcsy A; National Institute of Oncology, 1122 Budapest, Hungary.
  • Szász R; HCEMM-SE Molecular Oncohematology Research Group, Department of Pathology and Experimental Cancer Research, Semmelweis University, 1085 Budapest, Hungary.
  • Bödör C; Department of Laboratory Medicine, Karolinska Institute, 171 77 Solna, Sweden.
  • Alpár D; Division of Hematology, Department of Internal Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Int J Mol Sci ; 24(6)2023 Mar 18.
Article in En | MEDLINE | ID: mdl-36982875
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Agents Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2023 Document type: Article